Daman Samrao

Board-certified pathology professional with subspecialty training in breast and gynecology offering a solid background in hospital and laboratory environments. Highly experienced in leading staff, reviewing cases and consulting with physicians to guide and enhance patient diagnoses and treatment plans. Ready to take on a new professional challenge with an expanding operation.

• ESME Certification, 06/01/2022
• Diplomate of the American Board of Pathology, Anatomic and Clinical, 07/31/2013 - 12/31/YY
• ThinPrep Certification, 06/01/2013

• California, A117091
• Nevada, 15383
• Arizona, 49489

• College of American Pathologist (2009-current)
• American Society for Clinical Pathology (2009-current)
• United States and Canadian Academy of Pathology (2013-current)
• Clark County Medical Society (2021-current)

• Kirk Kekorian School of Medicine, Phase 1 Instructor for all Organ System Courses and Health Meets Food, 01/01/2020, current
• Kirk Kekorian School of Medicine, Phase 1 Course Director IMS, Pulmonology, Renal, Hematology, Musculoskeletal, 01/01/2020, current
• Kirk Kekorian School of Medicine, Phase 1 Organ System QRS Instructor, 01/01/2021, current
• Kirk Kekorian School of Medicine, Medical Education Summer Track Instructor, 06/01/2022, 08/01/2022
• Kirk Kekorian School of Medicine, Year 1 General Pathology and Year 2 Multidisciplinary Case Study, Clinical Assistant Professor, 01/01/2016, current
• University Medical Center Las Vegas, Pathology instructor for gynecologic oncology, current
• University of Pittsburgh School of Medicine, MS-1 Organ Based Systems Course, Pathology Lab Instructor – Reproductive Biology Course, 2014, 10 hours
• LAC+USC Department of Pediatrics, Glucose Monitor Training, Pathology Instructor, 07/01/2013, 2 hours
• LAC+USC, OB/GYN PGY-1 Microscopy Lab, Pathology Instructor, 07/01/2013, 2 hours

• Facilitating Social Bonding Between Incoming Medical Students Through Emergency Medical Technician (EMT) Training, IAMSE, 6/6/22,Creating a Collaborative Environment for Incoming Medical Students through EMT Training, WGEA, 4/1/22,
• Virtual Multidisciplinary Intervention using Question Review Sessions for At-Risk Students in Pre-Clerkship, WGEA, 4/1/22.
• Adenomyoepithelioma of the Breast: Case Report and Review of Literature for Aurora Diagnostic’s Case of the Month Digital Series, 8/1/2019.
• Berger JL, Samrao D, Huang M, Olawaiye AB. Primary gynecologic melanoma: A report of two unusual cases. Gynecol Oncol Rep. 2015 Jan 17; 11:31-3,
• Wong BJ, Hong BK, Samrao D, Kim GH, Rao NA. A 49 year old with unilateral, nontender left eyelid swelling. Digit J Ophthalmol. 2014 Jan 18;20(1):15-9.
• Mhawech-Fauceglia P, Wang D, Samrao D, Kim G, Lawrenson K, Meneses T, Liu S, Yessaian A, Pejovic T. Clinical implications of marker expression of carcinoma-associated fibroblasts (CAFs) in patients with epithelial ovarian carcinoma after treatment with neoadjuvant chemotherapy. Cancer Microenviron. 2014 Aug;7(1-2):33-9.
• Mhawech-Fauceglia P, Wang D, Samrao D, Liu S, DuPont NC, Pejovic T. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma. Gynecol Oncol. 2013 Jul; 130(1):174-80.
• Samrao D, Wang D, Ough F, Lin YG, Liu S, Meneses T, Yessaian A, Turner N, Pejovic T, Mhawech-Fauceglia P. Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy. Transl Oncol. 2012 Dec; 5(6):469-74.
• Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Ough F, Liu S, Pejovic T, Lele S. Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma. Gynecol Oncol. 2012 Oct;127(1):198-201.
• Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Pejovic T, Liu S, Lele S. Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer.Br J Cancer. 2012 Jul 10;107(2):370-4.
• Mhawech-Fauceglia P, Wang D, Samrao D, Meneses T, Godoy H, Ough F, Lele S, Liu S, Pejovic T. The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients. BMJ Open. 2012 Aug 24; 2(4).
• Benign Vulvar and Vaginal Pathology. Handbook of Gynecology. SpringerMeteor.
• Comparative study of Ki67 labeling index in HER2 amplified versus non-amplified estrogen receptor positive invasive carcinoma of the breast. USCAP 2014.
• Lee Summer Research Fellowship, Keck School of Medicine, USC, 2010 – “Expression of FGFs in Regenerating Cirrhotic Liver”.

7455 W Washington Ave #301, Las Vegas, NV 89128

dsamraosidhu@gmail.com

• Medical Reserve Corp, Volunteer, 01/01/2021, current